Akanda Other Operating Income or Expenses 2021-2024 | AKAN
Akanda other operating income or expenses from 2021 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
| Akanda Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2023 | $-3 |
| 2022 | $-8 |
| 2021 | $-1 |
| 2020 | $-1 |
| Akanda Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.002B | $0.001B |
| Akanda Corp. provides medical cannabis and wellness platform. The company's initial portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. Akanda Corp. is based in LONDON. | |||